Patent Assignment
Reel/Frame 057091/0229
Change of Name
Recorded: 2021-07-29
Pages: 4
Assignor
VIVUS, INC.
Executed: 2021-07-15
Assignee
VIVUS LLC
900 E. HAMILTON AVENUE, SUITE 550, CAMPBELL, CALIFORNIA, 95008
Covered Properties
(24)
Methods of Treating Obesity in Responder and Non-Responder Populations
Application:
17/333,191 →
Publication:
US 2021/0283096
Methods of Regulating Access to Qsymia to Mitigate Potential Drug-Associated Risks
Application:
16/732,508 →
Publication:
US 2020/0135318
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
Application:
16/796,189 →
Publication:
US 2020/0188313
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Application:
16/796,194 →
Publication:
US 2020/0188352
Methods of Preventing Progression to Type 2 Diabetes Melitus
Application:
16/733,559 →
Publication:
US 2020/0179332
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
Application:
16/590,703 →
Publication:
US 2020/0030239
Orally Administrable Formulations for the Controlled Release of a Pharmacologically Active Agent
Application:
16/822,308 →
Publication:
US 2020/0215091
Treatment of Sleep Apnea with a Combination of a Carbonic Anhydrase Inhibitor and an Aldosterone Antagonist
Application:
17/176,383 →
Publication:
US 2021/0161932
Combination Therapy for Pulmonary Hypertension
Application:
16/381,128 →
Publication:
US 2020/0069658
Combination Therapy for Pulmonary Hypertension
Application:
17/317,274 →
Publication:
US 2021/0267951
Compositions and Methods for the Treatment or Prevention of Pulmonary Hypertension
Application:
16/360,114 →
Publication:
US 2020/0054613
Compositions and Methods for the Treatment or Prevention of Pulmonary Hypertension
Application:
17/373,006 →
Publication:
US 2021/0338642
Pharmaceutical Formulations
Application:
16/893,998 →
Publication:
US 2021/0113477
Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors
Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors
Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof
Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity
Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
Methods of Preventing Progression to Type 2 Diabetes Mellitus
Methods of Preventing Progression to Type 2 Diabetes Mellitus
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 2007
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.; PETERSON, CRAIG
To: VIVUS, INC.
Reel/Frame 019490/0674 →
Assignment of Assignor's Interest
Sep 14, 2009
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 023228/0197 →
Assignment of Assignor's Interest
Sep 14, 2009
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 023228/0097 →
Assignment of Assignor's Interest
Apr 17, 2012
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.; PETERSON, CRAIG
To: VIVUS, INC.
Reel/Frame 028059/0924 →
Security Agreement
Apr 9, 2013
From: VIVUS. INC.
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 030183/0029 →
Affidavit of Address Change
Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0429 →
Affidavit of Address Change
Sep 30, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031314/0397 →
Affidavit of Address Change
Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0240 →
Affidavit of Address Change
Oct 11, 2013
From: VIVUS, INC.
To: VIVUS, INC.
Reel/Frame 031396/0242 →
Assignment of Assignor's Interest
Jan 30, 2015
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 034854/0350 →
Assignment of Assignor's Interest
Jan 30, 2015
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 034853/0846 →
Assignment of Assignor's Interest
Sep 4, 2015
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 036495/0068 →
Assignment of Assignor's Interest
Sep 14, 2016
From: NAJARIAN, THOMAS; TAM, PETER Y; WILSON, LELAND F
To: VIVUS, INC.
Reel/Frame 039739/0519 →
Assignment of Assignor's Interest
Mar 21, 2019
From: BANAIT, NARINDER S.; GU, LEO
To: VIVUS, INC.
Reel/Frame 048659/0279 →
Assignment of Assignor's Interest
Apr 11, 2019
From: GU, LEO; NAKAGAKI, PAUL C.; BANAIT, NARINDER S.
To: SELTEN PHARMA, INC.
Reel/Frame 048856/0522 →
Assignment of Assignor's Interest
Apr 11, 2019
From: SELTEN PHARMA, INC.
To: VIVUS, INC.
Reel/Frame 048856/0538 →
Release of Security Interest in Patents and Trademarks
Sep 25, 2019
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: VIVUS, INC.
Reel/Frame 050493/0669 →
Security Interest
Sep 30, 2019
From: VIVUS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 050570/0289 →
Assignment of Assignor's Interest
Oct 2, 2019
From: BROMAN, CALVIN THEODORE; SHEU, ERIC
To: VIVUS, INC.
Reel/Frame 050609/0736 →
Assignment of Assignor's Interest
Jan 2, 2020
From: MILLER, MICHAEL; TROUPIN, BARBARA
To: VIVUS, INC.
Reel/Frame 051401/0392 →
Assignment of Assignor's Interest
Jan 3, 2020
From: DAY, WESLEY; TROUPIN, BARBARA
To: VIVUS, INC.
Reel/Frame 051409/0825 →
Assignment of Assignor's Interest
Feb 21, 2020
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 051883/0939 →
Assignment of Assignor's Interest
Feb 21, 2020
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 051883/0935 →
Assignment of Assignor's Interest
Mar 18, 2020
From: BROMAN, CALVIN THEODORE; SHEU, ERIC
To: VIVUS, INC.
Reel/Frame 052151/0680 →
Assignment of Assignor's Interest
Jun 8, 2020
From: BANAIT, NARINDER S.; GU, LEO
To: VIVUS, INC.
Reel/Frame 052861/0468 →